Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSBS.L Regulatory News (SBS)

  • There is currently no data for SBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (DD) - Source BioScience plc

14 Sep 2016 16:45

RNS Number : 8700J
Source BioScience PLC
14 September 2016
 

FORM 8 (DD)

 

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Mr Laurie Turnbull (Chairman of Source BioScience plc)

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Source BioScience plc

(d) Status of person making the disclosure:

e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree)

Person acting in concert with the offeree

(e) Date dealing undertaken:

13 September 2016

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

3,048,667

0.8%

nil

-

(2) Cash-settled derivatives:

 

nil

-

nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

nil

-

nil

-

 

TOTAL:

3,048,667

0.8%

nil

-

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Ordinary shares of 2 pence each

 

Details, including nature of the rights concerned and relevant percentages:

 

Director

Maximum number of Ordinary Shares awarded

Date of Grant

First exercisable date

Last exercisable date

Option price (pence)

Laurie Turnbull

500,000

31 Mar 2008

31 Mar 2011

30 mar 2018

7.88p

400,000

26 Apr 2010

26 Apr 2013

25 Apr 2020

8.25p

 

 

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

(i) Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

n/a

n/a

n/a

n/a

 

(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

n/a

n/a

n/a

n/a

n/a

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

n/a

n/a

n/a

n/a

n/a

 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Ordinary shares of 2 pence each

Share options

Exercised

298,667

Nil

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

n/a

n/a

n/a

n/a

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

14 September 2016

Contact name:

Nick Ash (Company Secretary)

Telephone number:

+44 (0) 115 973 9010

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DCCAKQDQPBKDDCD
Date   Source Headline
23rd Jan 20142:46 pmRNSAdditional Listing on Exercise of Share Options
21st Jan 20149:00 amRNSNotification of Major Interest in Shares
9th Jan 20149:00 amRNSDirector/PDMR Shareholding
26th Nov 201310:36 amRNSHolding(s) in Company
25th Nov 201311:58 amRNSHolding(s) in Company
22nd Nov 201310:00 amRNSHolding(s) in Company
19th Nov 20137:00 amRNSInterim Management Statement
31st Oct 20133:50 pmRNSTotal Voting Rights
10th Oct 20133:22 pmRNSAdditional Listing on Exercise of Share Options
2nd Oct 20135:01 pmRNSHolding(s) in Company
2nd Oct 20134:59 pmRNSHolding(s) in Company
2nd Oct 20134:57 pmRNSHolding(s) in Company
2nd Oct 20134:57 pmRNSHolding(s) in Company
30th Sep 20133:46 pmRNSTotal Voting Rights
18th Sep 20135:00 pmRNSOffer Update
17th Sep 20137:00 amRNSOffer Update
16th Sep 20136:11 pmRNSTotal Voting Rights
12th Sep 20138:00 amRNSOFFER DECLARED UNCONDITIONAL AS TO ACCEPTANCES
2nd Sep 201310:42 amRNSNotification of major interest in shares
30th Aug 20132:39 pmRNSTotal Voting Rights
29th Aug 20138:00 amRNSOffer Update
29th Aug 20137:00 amPRNHalf-yearly Report
23rd Aug 201312:03 pmRNSResult of General Meeting
23rd Aug 201312:03 pmRNSResult of Open Offer
7th Aug 20132:20 pmRNSRecommended Cash Offer for Vindon Healthcare PLC
7th Aug 20132:20 pmRNSAnnouncement of Open Offer
1st Aug 20131:19 pmRNSUpdate on Irrevocable Undertakings
25th Jul 20137:00 amRNSUpdate re Funding for Possible Offer
24th Jul 20135:04 pmRNSUpdate re Funding for Possible Offer
22nd Jul 20135:55 pmRNSForm 8 (OPD) Vindon Healthcare PLC
17th Jul 20135:47 pmRNSForm 8.3 - Source BioScience
17th Jul 201311:49 amRNSForm 8.3 - Source Bioscience plc
16th Jul 20131:26 pmRNSForm 8.3 - Source BioScience Plc
16th Jul 20139:57 amRNSForm 8.3 - SOURCE BIOSCIENCE ORD GBP 0.02
16th Jul 20137:00 amRNSPossible Offer for Vindon
16th Jul 20137:00 amRNSPOSSIBLE OFFER FOR VINDON HEALTHCARE PLC
15th Jul 20136:23 pmRNSPOSSIBLE OFFER FOR VINDON HEALTHCARE PLC
15th Jul 20135:31 pmPRNPossible Offer for Vindon Healthcare plc
3rd Jul 20133:13 pmRNSNotification of major interest in shares
17th Jun 20137:00 amRNSNon Regulatory Announcement
12th Jun 20133:53 pmPRNResult of AGM
12th Jun 20137:00 amPRNAGM Statement
10th Jun 20134:12 pmRNSSBS supports Cervical Cancer Awareness Week
23rd May 20137:00 amPRNAnnual Information Update
17th May 201310:00 amPRNNotice of AGM
16th May 20137:00 amPRNInterim Management Statement
30th Apr 20137:00 amPRNAcquisition(s)
19th Mar 20137:00 amPRNFinal Results
18th Mar 20132:32 pmPRNNotification of major interest in shares
18th Mar 20132:31 pmPRNNotification re major interest in shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.